Active Not RecruitingNCT05476926
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Phase not reported · 6,000 planned enrolment
- Countries listed
- 29
- Registry update
- October 2, 2026
immortal.lifePublic trial registrations naming Hoffmann-La Roche as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
Phase not reported · 6,000 planned enrolment
Phase not reported · 875 planned enrolment
PHASE3 · 1,000 planned enrolment
PHASE3 · 250 planned enrolment